‘A two-stage prediction model for heterogeneous effects for many treatment options’ Konstantina Chalkou (University of Bern, Switzerland) XXXIst Conference of the Austro-Swiss Region [ ROeS ] of the International Biometric Society (Lausanne, Switzerland, September 9-12, 2019) DOWNLOAD
‘The need for better HTA methodology for more complex and personalised medicine’ Wim Goettsch, (Utrecht University, The Netherlands) Pharmaceutical Pricing and Reimbursement (PPRI) Conference (Vienna, Austria October 23-24, 2019) DOWNLOAD
‘Improving synergy between HTA bodies and regulatory agencies’ Richard Ofori-Asenso (University of Copenhagen, Denmark) Internal UCPH, Copenhagen Centre for Regulatory Science Scientific Advisory Board meeting (online event June 18, 2020) DOWNLOAD
‘HTx Next Generation Health Technology Assessment EU Horizon 2020 Project’ Dr Dalia Dawoud, (NICE, United Kingdom) GINAHTA webinar – HTA & Guidelines: What can we learn from each other? (online event June 29 2020) DOWNLOAD
‘The Future of Health Technology Assessment’ Dr Dalia Dawoud, (NICE, United Kingdom) 2nd Annual Conference of the BMC Journal of Pharmaceutical Policy and Practice (online event November 21 2020) DOWNLOAD
HTx Expert Forum meeting November 25, 2019 Barcelona (Spain) – Summary poster of results DOWNLOAD
HTx Deliverable 1.1: Systematic review on how (cost-) effectiveness of combinations of health technologies, individualised/personalised treatments and treatment pathways is currently being assessed by HTA bodies DOWNLOAD
HTx Deliverable 1.3: Review on treatment modalities for patient with myelodysplastic syndrome (MDS) DOWNLOAD
HTx Deliverable 1.4: Report describing the available data sources in relapsing-remitting Multiple Sclerosis case study 3 DOWNLOAD
HTx Deliverable 1.5: Report on the relevant treatment combinations for the T1DM and T2DM patients DOWNLOAD
HTx Deliverable 4.4: Overview of the development of the use of RWD including a review of national consensus methods currently developed DOWNLOAD